Zemaira Plant Tour
Visit the Zemaira Manufacturing Plant in Kankakee, Illinois
Learn first-hand about Zemaira and talk with the people who make it. Airfare, ground
transportation, and hotel accommodations for one night in addition to meals will
be provided by Caring Voice Coalition.
Tours are scheduled for:
- October 20, 2011
- March 15, 2012
- May 17, 2012
Spots are limited and available on a first-come, first-served basis.
Please contact Caring Voice Coalition at 1-888-267-1440 to register.
Important Safety Information
Alpha1-Proteinase Inhibitor (Human), Zemaira® is indicated for chronic augmentation and maintenance therapy for adults with alpha1-proteinase inhibitor (A1-PI) deficiency and emphysema. Clinical data demonstrating the long-term effects of chronic augmentation therapy with Zemaira are not available.
Zemaira may not be appropriate for the following adult individuals as they may experience severe reactions, including anaphylaxis: individuals with a known hypersensitivity and/or history of anaphylaxis or severe systemic reaction to A1-PI products or their components, and individuals with selective IgA deficiencies who have known antibodies against IgA.
In clinical studies, the following treatment-related adverse reactions were reported in 1% of subjects: asthenia (fatigue), injection-site pain, dizziness, headache, paresthesia (tingling), and pruritus (itching).
Zemaira is derived from human plasma. The risk of transmission of infectious agents, including viruses and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent, cannot be completely eliminated.
Please see full prescribing information.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.